Direct-acting antivirals
61 articles
Direct-Acting Antiviral Regimens and HCV Treatment Failure and Re-Treatment in Sub-Saharan Africa
The SHARED trial evaluated HCV treatment in treatment-naive patients in Rwanda with LDV-SOF. Two follow-up studies (SHARED-3) were published in The Lancet Gastroenterology & Hepatology. More
Safety and Efficacy of Ravidasvir Plus Sofosbuvir in Hepatitis C
The STORM-C-1 trial found that ravidasvir with sofosbuvir is well tolerated with excellent safety and efficacy in HCV infection, making it suitable for implementation in public health settings. More
Barriers to Scaling Up Hepatitis C Treatment in Malaysia
A study explored the barriers to scaling up HCV treatment in Malaysia from the perspective of key stakeholders. More
Gilead’s Claim That Generic Purchase of Sofosbuvir Would Lead to Patent Infringement in Brazil Dismissed
Gilead claims there is a patent infringement by two generic producers and directly asked to block any eventual commercialization of sofosbuvir products by these producers in Brazil. More
Gilead’s Claim That Generic Purchase of Sofosbuvir Would Lead to Patent Infringement in Brazil Dismissed
Gilead claims there is a patent infringement by two generic producers and directly asked to block any eventual commercialization of sofosbuvir products by these producers in Brazil. More
